Welcome to the #MEDIGRAM Patient Case: Chief Compliant Series. Short, concise patient cases to foster thought-provoking questions and to challenge you to ask questions! Make sure to by at the end of the week for explanations for the correct/incorrect answers.
💊 17yoM presents after being found unresponsive. Pinpoint pupils. Positive response to naloxone. Reports purchasing blue “M30” tablets.
Which of the following does not have a FDA-approved tablet formulation?
Let me know in the comments below!
Website: www.pharmwyze.com
Shop: www.pharmwyze.com/shop
Social Links: https://links.pharmwyze.com
DrugQueryInbox Request: https://pharmwyze.hopp.to/drugqueryinbox
Streaming Platforms: https://pharmwyze.hopp.to/podstreams
Patreon: https://patreon.com/PHARMWYZE
Paypal Donation: https://pharmwyze.hopp.to/paypaldonate
PHARMWYZE SITREP Newsletter: https://www.pharmwyze.com/sitrepnewsletter
Not medical advice. Educational purposes only. No relationships to report.
#MedicalInsights #ClinicalPearls #MedicalEducation #MedicineToday #pharmacist #pharmwyze #pharmfax #criticalcare #emergencymedicine #studentpharmacist #nursingstudent #medicalstudent #pharmacy #medicine #nursing #meded #shorts #rxshorts #medigram #medshed #foamed #emrx #pharmacology #pharmacokinetics #cardiology #antibiotics #neurology
Yorumlar